Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Fegan

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
British Journal of Haematology|November 20, 2008
Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemiaGuy Pratt, Stephen Harding, Roger Holder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabineSaman Hewamana, Thet Thet Lin, Chris Jenkins, et al.
Cancer|July 25, 2006
The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemiaSebastian Francis, Mamatha Karanth, Guy Pratt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2022
Mechanically Ventilated Patients Shed High-Titer Live Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for Extended Periods From Both the Upper and Lower Respiratory TractZack Saud, Mark Ponsford, Kirsten Bentley, et al.
Blood|June 12, 2010
Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisisThet Thet Lin, Boitelo T Letsolo, Rhiannon E Jones, et al.
Oncotarget|February 6, 2014
A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabineElisabeth Walsby, Guy Pratt, Hao Shao, et al.
Blood|July 5, 2008
Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markersChris Pepper, Thet Thet Lin, Guy Pratt, et al.
British Journal of Haematology|April 23, 2010
A polymorphism in the 3' UTR of IRF4 linked to susceptibility and pathogenesis in chronic lymphocytic leukaemia and Hodgkin lymphoma has limited impact in multiple myelomaGuy Pratt, James A L Fenton, David Allsup, et al.
British Journal of Haematology|March 26, 2017
Telomere length is a critical determinant for survival in multiple myelomaSam Hyatt, Rhiannon E Jones, Nicole H Heppel, et al.
British Journal of Haematology|April 25, 2009
Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rateJulio Delgado, Guy Pratt, Neil Phillips, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
British Journal of Haematology|November 20, 2008
Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemiaGuy Pratt, Stephen Harding, Roger Holder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabineSaman Hewamana, Thet Thet Lin, Chris Jenkins, et al.
Cancer|July 25, 2006
The effect of immunoglobulin VH gene mutation status and other prognostic factors on the incidence of major infections in patients with chronic lymphocytic leukemiaSebastian Francis, Mamatha Karanth, Guy Pratt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 1, 2022
Mechanically Ventilated Patients Shed High-Titer Live Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) for Extended Periods From Both the Upper and Lower Respiratory TractZack Saud, Mark Ponsford, Kirsten Bentley, et al.
Blood|June 12, 2010
Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisisThet Thet Lin, Boitelo T Letsolo, Rhiannon E Jones, et al.
Oncotarget|February 6, 2014
A novel Cdk9 inhibitor preferentially targets tumor cells and synergizes with fludarabineElisabeth Walsby, Guy Pratt, Hao Shao, et al.
Blood|July 5, 2008
Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markersChris Pepper, Thet Thet Lin, Guy Pratt, et al.
British Journal of Haematology|April 23, 2010
A polymorphism in the 3' UTR of IRF4 linked to susceptibility and pathogenesis in chronic lymphocytic leukaemia and Hodgkin lymphoma has limited impact in multiple myelomaGuy Pratt, James A L Fenton, David Allsup, et al.
British Journal of Haematology|March 26, 2017
Telomere length is a critical determinant for survival in multiple myelomaSam Hyatt, Rhiannon E Jones, Nicole H Heppel, et al.
British Journal of Haematology|April 25, 2009
Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rateJulio Delgado, Guy Pratt, Neil Phillips, et al.
Pageof 6